PATRICK SMITH: Open Payments
NPI 1831758044 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,443 in 141 payments from 22 companies in 2025. Trend: 2023 $2,171 · 2024 $2,148 · 2025 $2,443
Food & beverage: $2,443
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $553 |
| GlaxoSmithKline, LLC. | 9 | $239 |
| Lilly USA, LLC | 9 | $233 |
| Astellas Pharma US Inc | 10 | $207 |
| AstraZeneca Pharmaceuticals LP | 7 | $159 |
| PFIZER INC. | 7 | $146 |
| Exact Sciences Corporation | 5 | $123 |
| Novo Nordisk Inc | 5 | $121 |
| Teva Pharmaceuticals USA, Inc. | 7 | $117 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
Products named: VRAYLAR, TRELEGY ELLIPTA, Veozah, JARDIANCE, REXULTI, AUSTEDO XR, AIRSUPRA, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
